Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis..
Lancet. 376(9756), 1916-22.
(2010). Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review..
Curr Med Res Opin. 29(10), 1263-74.
(2013). Mortality reduction in patients treated with intensive lipid therapy vs usual care. Re: Zhao XQ, Phan BA, Davis J et al. Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosis Tre.
J Clin Lipidol. 11(1), 306-307.
(2017). Editorial: microRNAs: Potential Targets for the Treatment of Cardiovascular Disease..
Curr Vasc Pharmacol. 13(3), 366-7.
(2015). To switch (statins) or not to switch? That is the question..
Expert Opin Pharmacother. 11(18), 2943-6.
(2010). Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with CHD and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study..
Nephrol Dial Transplant. 22(1), 118-27.
(2007). High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus..
J Diabetes Complications. 29(1), 142-5.
(2015). Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study..
Curr Med Res Opin. 27(8), 1659-68.
(2011). Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis..
Angiology. 63(5), 358-66.
(2012). Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?.
Curr Med Res Opin. 26(4), 839-42.
(2010). Do we need to consider inflammatory markers when we treat atherosclerotic disease?.
Atherosclerosis. 200(1), 1-12.
(2008). Undertreatment of dyslipidemia: from the Arabian Gulf to the USA. Time to solve this problem!.
Curr Med Res Opin. 30(12), 2425-8.
(2014). Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels..
Curr Drug Targets. 8(3), 483-8.
(2007). Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients..
Open Cardiovasc Med J. 1, 8-14.
(2007). Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study..
Arch Med Sci. 7(5), 796-805.
(2011). Embryo with XYY syndrome presenting with clubfoot: a case report..
Cases J. 2, 8404.
(2009). Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial..
Clin Exp Obstet Gynecol. 42(3), 347-51.
(2015). Spinal epidural extraskeletal Ewing sarcoma in an adolescent boy: a case report..
Pediatr Hematol Oncol. 23(3), 263-7.
(2006). Recent Findings in Alzheimer Disease and Nutrition Focusing on Epigenetics..
Adv Nutr. 7(5), 917-27.
(2016). Influenza surveillance during the post-pandemic influenza 2010/11 season in Greece, 04 October 2010 to 22 May 2011..
Euro Surveill. 16(44),
(2011). Lasting bilateral mydriasis after traumatic brain injury may not always be a lost case..
Surg Neurol Int. 8, 229.
(2017). A Systematic Review of Investigations into Functional Brain Connectivity Following Spinal Cord Injury..
Front Hum Neurosci. 11, 517.
(2017). Molecular and Clinical Investigation of Cystinuria in the Greek-Cypriot Population..
Genet Test Mol Biomarkers. 19(11), 641-5.
(2015). Investigating the Role of Alpha and Beta Rhythms in Functional Motor Networks..
Neuroscience. 378, 54-70.
(2018).
(2015).